美國醫療用營養品市場

本報告已在2011年07月07日停止出版。

更改為出版

醫療用營養劑的美國/全球市場

U.S. and Global Markets for Ethical Nutrition in Healthcare

出版日期 : 2011年06月

商品編碼: 203862

簡介

目錄

Abstract

INTRODUCTION

The objectives of this study are to present an updated, in-depth look at ethical nutrition in healthcare. Markets are divided according to product type. It is directed to decision-makers involved with the various types of nutritional products covered, and designed to present insights into those areas associated with current and future developments.

SCOPE OF STUDY

This report:

• Profiles and measures the U.S. market for ethical nutrition in healthcare with comprehensive focus on markets for infant and adult enteral and parenteral nutrition and nutritional supplies and equipment.
• Includes a comparative overview of nutrition and its function in the human body, as well as definitions of products and product types within each market as well ethical nutrition supplies and equipment.
• Analyzes all market segments with forecasts by sector and sub-sector through 2011.
• Includes analysis of regulatory issues and industry structure, R&D updates, and patent analysis.

METHODOLOGY AND INFORMATION SOURCES

The information and analyses presented in this report are based on extensive first hand interviews with primary executives, product managers, and clinical specialists in the area of ethical nutrition. Random surveying provided information about product use and how products are obtained. Background information was obtained from various government and business sources, medical journals, and trade magazines as well as interviews with doctors and dieticians.

Key information from published literature was used as a basis for conducting interviews with more than 21 industry participants to validate and obtain expert opinions on current and future trends in ethical nutrition in healthcare. Interviews also were used to confirm and/or adjust market size and competitor market share estimates, as well as to formulate market projections.

All data pertain to the U.S. market at the manufacturer' s level. Data are expressed in current U.S. dollars. The base year was 2007; historical data are provided for 2005 and 2006, and forecast data are provided for 2012. Historical, base year and forecast data are provided for each market segment and subsegment. Market share information is provided for each market subsegment for the 2007 base year.

Table of Contents

• INTRODUCTION
  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE AND FORMAT
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • DISCLAIMER
• SUMMARY
  • Summary Table:
  • MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Summary Figure:
  • TOTAL REVENUES OF U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY AT MANUFACTURERS' SALES LEVELS ($ MILLIONS)
• INDUSTRY OVERVIEW
  • DEFINITION OF ETHICAL NUTRITION
    • HUMAN DIGESTION
    • STRUCTURES AND FUNCTIONS OF THE GASTROINTESTINAL SYSTEM
      • Structures and Functions ...(Continued)
    • DIGESTION AND ABSORPTION
      • Digestion and Absorption (Continued)
      • Digestion and Absorption (Continued)
      • Digestion and Absorption (Continued)
    • EFFECTS OF AGING
    • NUTRITION
  • Table 1 ESSENTIAL NUTRIENTS REQUIRED FOR HEALTH
  • Figure 1 DAILY MEAN ENERGY INTAKE FOR PERSONS AGES 2 MONTHS TO 19 YEARS (%)
    • MALNUTRITION
    • TYPES OF SUPPLEMENTAL NUTRITION
      • Oral Feeding
      • Tube Feeding
      • Total Parenteral Nutrition
    • IMPORTANCE OF THE INDUSTRY
    • HISTORY OF THE INDUSTRY
      • INFANT NUTRITION
      • PEDIATRIC ENTERAL NUTRITION
  • Table 2 CONTINUOUS VERSUS INTERMITTENT FEEDINGS
    • ADULT ENTERAL NUTRITION
    • PARENTERAL NUTRITION
  • REGULATORY ENVIRONMENT
    • THE INFANT FORMULA ACT OF 1980
      • The 1986 Amendments to the Infant Formula Act
    • REALIGNMENT OF THE CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
    • SAFETY
    • COST CONTAINMENT
    • ADVERTISING
    • PACKAGING
    • END-USER ISSUES
    • DEMOGRAPHICS
  • Table 3 TOTAL U.S. LIVE BIRTH RATES, 1960-2005 (THOUSANDS)
  • Figure 2 TOTAL U.S. LIVE BIRTH RATES, 1960-2005 (THOUSANDS)
  • Table 4 U.S. POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2005-2030 (THOUSANDS)
  • Figure 3 U.S. POPULATION BY SELECTED AGE GROUPS, 2005-2012 (THOUSANDS)
  • Figure 4 PERCENT U.S. POPULATION BY SELECTED AGE GROUPS, 2005-2012 (%)
    • FORMULAS WITH DHA AND ARA ADDED
      • DHA, ARA AND INFANT GROWTH
        • DHA, ARA and Infant Growth (Continued)
      • GENETICALLY ENGINEERED PRODUCTS
      • ENTERAL VS PARENTERAL NUTRITION
      • INTERNET CAUTIONS
      • PERCUTANEOUS ENDOSCOPIC GASTROSTOMY
      • FIBER-BOOSTED FORMULA
      • FUTURE TRENDS
        • FUTURE TRENDS (CONTINUED)
• INFANT AND PEDIATRIC NUTRITION
  • DEFINITION OF INFANT FORMULA
  • INFANT FORMULA REGULATION
    • GENERAL INGREDIENT SAFETY REQUIREMENTS
    • REQUIREMENTS SPECIFIC TO INFANT FORMULA
      • Requirements Specific ...(Continued)
    • BREAST MILK VS. INFANT FORMULA
  • Table 5 PHASES OF BREAST MILK PRODUCTION
    • Breast Milk vs. ... (continued)
    • Breast Milk vs. ... (continued)
  • Table 6 NUTRITIONAL COMPARISON OF BREAST MILK AND COMMERCIAL INFANT FORMULAS
  • Table 6 (CONTINUED)
  • Table 7 VITAMIN COMPOSITION COMPARISON OF BREAST MILK AND COMMERCIAL INFANT FORMULAS
  • Table 7 (CONTINUED)
    • NEW GROWTH CHARTS
    • FACTORS IMPACTING INFANT FORMULA GROWTH
      • WIC PROGRAM
        • WIC Program (Continued)
        • WIC Program (Continued)
        • WIC Contract Bidding
      • INFANT FORMULA AND LIFE-LONG OBESITY AND DIABETES
        • MILK-BASED INFANT FORMULA
          • Product Description
            • Product Description (Continued)
            • Product Description (Continued)
            • Product Description (Continued)
          • New Developments
        • SOY-BASED INFANT FORMULA
          • Product Description
            • Product Description (Continued)
        • DISEASE-SPECIFIC PEDIATRIC FORMULAS
  • Table 8 CONDITIONS AFFECTING NUTRITION
  • Table 8 (CONTINUED)
    • Disease-specific Pediatric ... (continued)
    • Disease-specific Pediatric ... (continued)
    • Product Description
  • PEDIATRIC FORMULAS AND SUPPLEMENTS
    • Product Description
      • Product Description (Continued)
  • Table 9 SELECTED PEDIATRIC NUTRITIONAL COMPOSITIONS
  • Table 9 (CONTINUED)
    • INFANT AND PEDIATRIC NUTRITION MARKET ANALYSIS
  • Table 10 MARKET FORECAST FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Figure 5 MARKET FORECAST FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
  • Table 11 MARKET SHARE FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 6 REVENUE DISTRIBUTION FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
    • MILK-BASED INFANT FORMULA
  • Table 12 U.S. MILK-BASED INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 7 U.S. MILK-BASED INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • SOY-BASED INFANT FORMULA
  • Table 13 U.S. SOY-BASED INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 8 U.S. SOY-BASED INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • SPECIALIZED INFANT FORMULAS AND PEDIATRIC SUPPLEMENTS
  • Table 14 U.S. SPECIALIZED PEDIATRIC FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 9 U.S. SPECIALIZED PEDIATRIC FORMULA MANUFACTURERS' MARKET SHARE, 2007 (%)
    • DISEASE-SPECIFIC INFANT FORMULAS AND PEDIATRIC SUPPLEMENTS
  • Table 15 U.S. DISEASE-SPECIFIC INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 10 U.S. DISEASE-SPECIFIC INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
• ADULT ENTERAL NUTRITION
  • INTRODUCTION
    • ADULT ENTERAL NUTRITION (CONTINUED)
  • Table 16 ENTERAL FEEDING ROUTES
  • Table 16 (CONTINUED)
  • Table 17 ENTERAL FEEDING: ADMINISTRATION METHODS
  • Table 17 (CONTINUED)
    • ADULT ENTERAL NUTRITION (CONTINUED)
    • ADULT ENTERAL NUTRITION (CONTINUED)
  • FACTORS IMPACTING GROWTH
  • INTACT ADULT ENTERAL FORMULA
    • PRODUCT DESCRIPTION
    • NEW DEVELOPMENTS
  • MODULAR ADULT ENTERAL FORMULA
    • PRODUCT DESCRIPTION
      • Product Description (Continued)
  • DISEASE-SPECIFIC ADULT ENTERAL FORMULA
    • PRODUCT DESCRIPTION
      • Product Description (Continued)
    • ELEMENTAL AND REHYDRATION ADULT ENTERAL FORMULA
      • PRODUCT DESCRIPTION
    • ADULT ENTERAL NUTRITION MARKET ANALYSIS
  • Table 18 MARKET FORECAST FOR U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Figure 11 MARKET FORECAST FOR U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
  • Table 19 MARKET SHARE OF U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 12 DISTRIBUTION OF REVENUES FROM U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
    • INTACT ADULT ENTERAL NUTRITION
  • Table 20 U.S. INTACT ADULT ENTERAL NUTRITION: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 13 U.S. INTACT ADULT ENTERAL NUTRITION: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • MODULAR ADULT ENTERAL NUTRITION
  • Table 21 U.S. MODULAR ADULT ENTERAL: FORMULA MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 14 U.S. MODULAR ADULT ENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • DISEASE-SPECIFIC ADULT FORMULAS
      • Disease-specific Adult ... (Continued)
  • Table 22 U.S. DISEASE-SPECIFIC ADULT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 15 U.S. DISEASE-SPECIFIC ADULT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • ELEMENTAL AND REHYDRATION FORMULAS
  • Table 23 U.S. ELEMENTAL AND REHYDRATION FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 16 U.S. ELEMENTAL AND REHYDRATION FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
• PARENTERAL NUTRITION
  • INTRODUCTION
    • INTRODUCTION (CONTINUED)
  • PHOTODEGRADATION/OXIDATION REACTIONS
  • SORPTION LOSSES
  • HYDROLYSIS REACTIONS
  • COPRECIPITATION FROM DEGRADATION PRODUCTS
  • METABOLIC AND BIOCHEMICAL FACTORS CONTRIBUTING TO VITAMIN DEFICIENCY
    • THIAMINE STATUS IN TPN
    • VITAMIN C
    • OTHER VITAMIN DEFICIENCIES
  • TPN AND CANCER PATIENTS
    • TPN AND CANCER PATIENTS (CONTINUED)
  • FACTORS IMPACTING GROWTH
  • AMINO ACID PARENTERAL FORMULA
    • PRODUCT DESCRIPTION
  • FATS PARENTERAL FORMULA
    • PRODUCT DESCRIPTION
  • DEXTROSE PARENTERAL FORMULA
    • PRODUCT DESCRIPTION
  • MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULAS
    • PRODUCT DESCRIPTION
  • Table 24 RECOMMENDATIONS FOR PARENTERAL VITAMIN INTAKE
  • Table 25 RECOMMENDATIONS FOR PARENTERAL MINERAL INTAKE
  • Table 26 FACTORS THAT INCREASE OR DECREASE ELECTROLYTE NEEDS
    • PARENTERAL NUTRITION MARKET ANALYSIS
  • Table 27 MARKET FORECAST FOR U.S. PARENTERAL NUTRITION PRODUCTS, THROUGH 2012 ($ MILLIONS)
  • Figure 17 MARKET FORECAST FOR U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
  • Table 28 MARKET SHARE OF U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 18 DISTRIBUTION OF REVENUES FROM U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
    • AMINO ACID PARENTERAL FORMULAS
  • Table 29 U.S. AMINO ACID PARENTERAL SOLUTION: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 19 U.S. AMINO ACID PARENTERAL SOLUTION: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • FATS PARENTERAL FORMULAS
  • Table 30 U.S. FATS PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 20 U.S. FATS PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • DEXTROSE PARENTERAL FORMULAS
  • Table 31 DEXTROSE PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 21 DEXTROSE PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULAS
  • Table 32 U.S. MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 22 U.S. MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
• ETHICAL NUTRITION SUPPLIES AND EQUIPMENT
  • INTRODUCTION
  • FACTORS IMPACTING GROWTH
    • FACTORS IMPACTING GROWTH (CONTINUED)
  • ENTERAL SUPPLIES AND EQUIPMENT MARKET
    • PRODUCT DESCRIPTION
      • Product Description (Continued)
    • PARENTERAL SUPPLIES AND EQUIPMENT MARKET
      • PARENTERAL SUPPLIES AND ...(CONTINUED)
    • ADMINISTRATION SETS
      • PRODUCT DESCRIPTIONS
    • ETHICAL NUTRITION SUPPLIES AND EQUIPMENT MARKET ANALYSIS
  • Table 33 MARKET FORECAST FOR U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT, THROUGH 2012 ($ MILLIONS)
  • Figure 23 MARKET FORECAST FOR U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT, 2005-2012 ($ MILLIONS)
  • Table 34 MARKET SHARE OF U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 24 REVENUE DISTRIBUTION FROM U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT BY CATEGORY, 2005-2012 (%)
    • ENTERAL DELIVERY SYSTEMS SUPPLIES AND EQUIPMENT
  • Table 35 U.S. ENTERAL DELIVERY SYSTEM SUPPLIES AND EQUIPMENT: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 25 U.S. ENTERAL DELIVERY SYSTEM SUPPLIES AND EQUIPMENT MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 (%)
    • IV OR PARENTERAL SUPPLIES AND EQUIPMENT
  • Table 36 U.S. PARENTERAL SUPPLIES AND EQUIPMENT: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 26 U.S. PARENTERAL SUPPLIES AND EQUIPMENT: MANUFACTURERS' MARKET SHARE, 2007 (%)
    • ADMINISTRATION SETS
  • Table 37 U.S. ADMINISTRATION SET: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Figure 27 U.S. ADMINISTRATION SET: MANUFACTURERS' MARKET SHARE, 2007 (%)
• TOTAL MARKET SUMMARY
  • Table 38 MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Figure 28 MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
    • TOTAL MARKET PERCENTAGE BY PRODUCT TYPE
  • Table 39 TOTAL REVENUES, MARKET SHARES, AND NUMBERS OF MANUFACTURERS OF U.S. ETHICAL NUTRITION PRODUCTS BY MARKET SEGMENT, 2007 ($ MILLIONS)
  • Figure 29 PERCENT SHARES OF U.S. ETHICAL NUTRITION PRODUCTS BY MARKET SEGMENT, 2007 (%)
• INDUSTRY PARTICIPANTS BY PRODUCT TYPE
  • Table 40 ETHICAL NUTRITION INDUSTRY PARTICIPANTS BY PRODUCT CATEGORY, 2006-2007
  • Table 40 (CONTINUED)
    • COMPANY PROFILES
      • ALARIS MEDICAL SYSTEMS, INC. (CARDINAL HEALTH)
      • BAXTER INTERNATIONAL, INC.
      • B. BRAUN MELSUNGEN AG
      • HOSPIRA, INC.
      • KENDALL HEALTHCARE PRODUCTS
      • MEAD JOHNSON NUTRITIONAL GROUP
      • NESTLE USA, INC.
      • NOVARTIS MEDICAL NUTRITION
      • ROSS PRODUCTS DIVISION
      • PBM PRODUCTS, LLC
      • ZEVEX INTERNATIONAL, INC.
• APPENDIX I
  • LIST OF COMPANIES
    • LIST OF COMPANIES (CONTINUED)
    • LIST OF COMPANIES (CONTINUED)
    • LIST OF COMPANIES (CONTINUED)
    • LIST OF COMPANIES (CONTINUED)
    • LIST OF COMPANIES (CONTINUED)
    • LIST OF COMPANIES (CONTINUED)
• LIST OF TABLES
  • Summary Table:
  • MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Table 1 ESSENTIAL NUTRIENTS REQUIRED FOR HEALTH
  • Table 2 CONTINUOUS VERSUS INTERMITTENT FEEDINGS
  • Table 3 TOTAL U.S. LIVE BIRTH RATES, 1960-2005 (THOUSANDS)
  • Table 4 U.S. POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2005-2030 (THOUSANDS)
  • Table 5 PHASES OF BREAST MILK PRODUCTION
  • Table 6 NUTRITIONAL COMPARISON OF BREAST MILK AND COMMERCIAL INFANT FORMULAS
  • Table 7 VITAMIN COMPOSITION COMPARISON OF BREAST MILK AND COMMERCIAL INFANT FORMULAS
  • Table 8 CONDITIONS AFFECTING NUTRITION
  • Table 9 SELECTED PEDIATRIC NUTRITIONAL COMPOSITIONS
  • Table 10 MARKET FORECAST FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Table 11 MARKET SHARE FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Table 12 U.S. MILK-BASED INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 13 U.S. SOY-BASED INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 14 U.S. SPECIALIZED PEDIATRIC FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 15 U.S. DISEASE-SPECIFIC INFANT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 16 ENTERAL FEEDING ROUTES
  • Table 17 ENTERAL FEEDING: ADMINISTRATION METHODS
  • Table 18 MARKET FORECAST FOR U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Table 19 MARKET SHARE OF U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Table 20 U.S. INTACT ADULT ENTERAL NUTRITION: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 21 U.S. MODULAR ADULT ENTERAL: FORMULA MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 22 U.S. DISEASE-SPECIFIC ADULT FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 23 U.S. ELEMENTAL AND REHYDRATION FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 24 RECOMMENDATIONS FOR PARENTERAL VITAMIN INTAKE
  • Table 25 RECOMMENDATIONS FOR PARENTERAL MINERAL INTAKE
  • Table 26 FACTORS THAT INCREASE OR DECREASE ELECTROLYTE NEEDS
  • Table 27 MARKET FORECAST FOR U.S. PARENTERAL NUTRITION PRODUCTS, THROUGH 2012 ($ MILLIONS)
  • Table 28 MARKET SHARE OF U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Table 29 U.S. AMINO ACID PARENTERAL SOLUTION: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 30 U.S. FATS PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 31 DEXTROSE PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 32 U.S. MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULA: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 33 MARKET FORECAST FOR U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT, THROUGH 2012 ($ MILLIONS)
  • Table 34 MARKET SHARE OF U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Table 35 U.S. ENTERAL DELIVERY SYSTEM SUPPLIES AND EQUIPMENT: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 36 U.S. PARENTERAL SUPPLIES AND EQUIPMENT: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 37 U.S. ADMINISTRATION SET: MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 ($ MILLIONS)
  • Table 38 MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Table 39 TOTAL REVENUES, MARKET SHARES, AND NUMBERS OF MANUFACTURERS OF U.S. ETHICAL NUTRITION PRODUCTS BY MARKET SEGMENT, 2007 ($ MILLIONS)
  • Table 40 ETHICAL NUTRITION INDUSTRY PARTICIPANTS BY PRODUCT CATEGORY, 2006-2007
• LIST OF FIGURES
  • Summary Figure:
  • TOTAL REVENUES OF U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY AT MANUFACTURERS' SALES LEVELS ($ MILLIONS)
  • Figure 1 DAILY MEAN ENERGY INTAKE FOR PERSONS AGES 2 MONTHS TO 19 YEARS (%)
  • Figure 2 TOTAL U.S. LIVE BIRTH RATES, 1960-2005 (THOUSANDS)
  • Figure 3 U.S. POPULATION BY SELECTED AGE GROUPS, 2005-2030 (THOUSANDS)
  • Figure 4 PERCENT U.S. POPULATION BY SELECTED AGE GROUPS, 2005-2030 (%)
  • Figure 5 MARKET FORECAST FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
  • Figure 6 REVENUE DISTRIBUTION FOR U.S. INFANT AND PEDIATRIC NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 7 U.S. MILK-BASED INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 8 U.S. SOY-BASED INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 9 U.S. SPECIALIZED PEDIATRIC FORMULA MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 10 U.S. DISEASE-SPECIFIC INFANT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 11 MARKET FORECAST FOR U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
  • Figure 12 DISTRIBUTION OF REVENUES FROM U.S. ADULT NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 13 U.S. INTACT ADULT ENTERAL NUTRITION: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 14 U.S. MODULAR ADULT ENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 15 U.S. DISEASE-SPECIFIC ADULT FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 16 U.S. ELEMENTAL AND REHYDRATION FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 17 MARKET FORECAST FOR U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 ($ MILLIONS)
  • Figure 18 DISTRIBUTION OF REVENUES FROM U.S. PARENTERAL NUTRITION PRODUCTS BY CATEGORY, 2005-2012 (%)
  • Figure 19 U.S. AMINO ACID PARENTERAL SOLUTION: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 20 U.S. FATS PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 21 DEXTROSE PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 22 U.S. MICRONUTRIENT AND MULTIVITAMIN PARENTERAL FORMULA: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 23 MARKET FORECAST FOR U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT, 2005-2012 ($ MILLIONS)
  • Figure 24 REVENUE DISTRIBUTION FROM U.S. ETHICAL NUTRITION SUPPLIES AND EQUIPMENT BY CATEGORY, 2005-2012 (%)
  • Figure 25 U.S. ENTERAL DELIVERY SYSTEM SUPPLIES AND EQUIPMENT MANUFACTURERS' REVENUES AND MARKET SHARE, 2007 (%)
  • Figure 26 U.S. PARENTERAL SUPPLIES AND EQUIPMENT: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 27 U.S. ADMINISTRATION SET: MANUFACTURERS' MARKET SHARE, 2007 (%)
  • Figure 28 MARKET FORECAST FOR U.S. ETHICAL NUTRITION PRODUCTS BY CATEGORY, THROUGH 2012 ($ MILLIONS)
  • Figure 29 PERCENT SHARES OF U.S. ETHICAL NUTRITION PRODUCTS BY MARKET SEGMENT, 2007 (%)

相關商品

矚目市場調查報告書

全套市場調查報告定期訂閱

Market Research Report Subscription

BCC Research發行的製藥相關市場調查報告書

全球的肝臟疾病治療藥市場

Liver Disease Treatments: The Global Market

價格 : US $ 4850

出版日期 : 2012年01月

2011年醫療市場調査評論

2011 Healthcare Research Review

價格 : US $ 850

出版日期 : 2012年01月

肺部給藥系統:技術和全球市場

Pulmonary Drug Delivery Systems: Technologies and Global Markets

價格 : US $ 4850

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!